Literature DB >> 5303620

Characterization of a human serum inhibitor of Clostridium histolyticum proteinase(s).

A Luzzati, M B Goldlust, L Levine.   

Abstract

Normal animal sera inhibit at least one Clostridium histolyticum proteinase. An assay procedure based on immune hemolysis was developed for the estimation of this inhibition. This inhibitory activity occurs in various levels in the sera of different animal species. The highest titers have been obtained with rat sera. The inhibitory activity from human serum was isolated and purified 16- to 27-fold by Sephadex G-200 gel filtration and diethylaminoethyl cellulose or hydroxylapatite chromatography. The properties of the human serum inhibitor of the clostridial proteinase were compared with a trypsin inhibiting factor found in the partially purified preparations. Identical behavior of the two inhibitory factors was observed when measured by heat inactivation, beta-mercaptoethanol sensitivity, pH stability, and sucrose gradient centrifugation. The inhibitory factor has an approximate sedimentation coefficient (S(20,w)) of 17. Goat anti-alpha-2-macroglobulin specifically precipitated the clostridial proteinase inhibitor from a partially purified preparation.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5303620      PMCID: PMC252542          DOI: 10.1128/jb.96.6.1969-1976.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  12 in total

1.  Trypsin inhibitors of human serum. II. Isolation of the alpha 1-inhibitor and its partial characterization.

Authors:  H F BUNDY; J W MEHL
Journal:  J Biol Chem       Date:  1959-05       Impact factor: 5.157

2.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

3.  Quantitative estimation of antigens by complement fixation; studies on the heat-labile alpha-2 glycoprotein.

Authors:  A PETERKOFSKY; L LEVINE; R K BROWN
Journal:  J Immunol       Date:  1956-03       Impact factor: 5.422

4.  Inhibition of Proteinases of Certain Clostridia by Serum.

Authors:  L D Smith; C H Lindsley
Journal:  J Bacteriol       Date:  1939-08       Impact factor: 3.490

5.  A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase.

Authors:  R F BEERS; I W SIZER
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

6.  Dissociation of esterolytic and clotting activities of thrombin by trypsin-binding macroglobulin.

Authors:  G F Lanchantin; M L Plesset; J A Friedmann; D W Hart
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

7.  Complement-inactivating proteinase(s) from Clostridium histolyticum.

Authors:  M B Goldlust; A Luzzati; L Levine
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

8.  Enzymatic debridement of third-degree burns on guinea pigs by Clostridium histolyticum proteinases.

Authors:  M E WEBSTER; P L ALTIERI; D A CONKLIN; S BERMAN; J P LOWENTHAL; R B GOCHENOUR
Journal:  J Bacteriol       Date:  1962-03       Impact factor: 3.490

9.  TURBIDIMETRIC CHANGES ACCOMPANYING THE INTERACTION OF ENDOTOXIN AND THE ALPHA-CHAINS OF HUMAN HEMOGLOBIN.

Authors:  P SETLOW; L LEVINE; H VANVUNAKIS
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

10.  THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.

Authors:  G B NAFF; J PENSKY; I H LEPOW
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

View more
  2 in total

1.  Action of a phospholipase C preparation on the first component of complement of guinea pig and human serum: lack of correlation with enzyme activity.

Authors:  G M Loos; T Borsos
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

2.  Complement-inactivating proteinase(s) from Clostridium histolyticum.

Authors:  M B Goldlust; A Luzzati; L Levine
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.